Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology Center (SGTC) at International Park in Gurgaon, India, the Keystone Suite will enable collaboration between customers, product development engineers, cross-functional teams, and other key stakeholders, according to a company press release.
The release further notes that, in India, scarcity of professional care and infrastructure are key factors in the country’s treatment rates for stroke, but that Stryker’s NV lab offers an “ideal environment” for medical education, research and development, and customer engagement activities designed to improve patient outcomes.
The lab has three main components: a neurovascular catheterisation laboratory (cath lab) designed to mimic the hospital treatment experience with the latest imaging and communication equipment; a performance lab with hands-on stations outfitted with flow models, neurovascular simulators and 3D-model-printing capabilities; and planned space for physician interaction.
Mark O’Brien, vice president and general manager for the Neurovascular division at Stryker, said: “Asia Pacific is our fastest growing region, and a big part of our future growth plans. We are continuing to invest in the region to facilitate innovation and advance stroke care.”
Ram Rangarajan, vice president of the Stryker Global Technology Center, added: “We are excited to bring this advanced lab and its capabilities to India’s neurointerventionalist community, and to help grow the specialty in the country. We believe in the concept of public-private partnerships, and invite the government to collaborate with us to train future physicians.”
